ARTICLES BY SUZANNE HODSDEN

  • Industry Groups Optimistic Over Re-Authorization of MDUFA
    Industry Groups Optimistic Over Re-Authorization of MDUFA

    The FDA and several industry advocacy groups have reached a tentative agreement regarding the fourth re-authorization of the Medical Device User Fee Agreement (MDUFA), which is slated for delivery to congress in January of 2017. Under the re-authorization, the FDA will collect close to $1 billion in user fees, money that will be allocated to fund several improvements to the FDA’s review process.

  • Baxter, Satellite Healthcare Partner To Improve Patient Access To Latest Dialysis Technology
    Baxter, Satellite Healthcare Partner To Improve Patient Access To Latest Dialysis Technology

    Baxter has signed a four-year agreement with Satellite Healthcare, a non-profit organization that provides kidney dialysis and other related services. Baxter’s latest technology in peritoneal dialysis, hemodialysis, and continuous renal replacement therapy will be incorporated into Satellite Healthcare’s service offerings for over 7,000 patients in the U.S.

  • Batteries Made From Melanin Could Power Ingestible Devices
    Batteries Made From Melanin Could Power Ingestible Devices

    Scientists from Carnegie Mellon University (CMU) have developed a battery made from melanin, a naturally occurring compound in human skin, eyes and hair, which they say can power a 5 milliWatt device for 18 hours.

  • FDA Clears First Computerized Cognitive Test For Concussion
    FDA Clears First Computerized Cognitive Test For Concussion

    The FDA has for the first time cleared a computerized diagnostic device designed specifically to evaluate a patient’s cognitive function immediately following a head injury and a suspected traumatic brain injury (TBI), otherwise known as concussion. While the Immediate Post-Concussion Assessment and Cognitive Testing (imPACT) device cannot conclusively diagnose TBI on its own, or direct a course of treatment, the tool offers point-of-care quantitative evaluation to assist trained healthcare providers in making treatment decisions.

  • Handheld Device Lets Patients “Test-Drive” Lens Implants
    Handheld Device Lets Patients “Test-Drive” Lens Implants

    A new handheld device may better equip patients in their decision-making process when choosing an intraocular lens (IOL) implant. The SimVis, developed by Spanish scientists, was tested with cataract surgery candidates, and researchers found patients had a clear preference for certain implants based on their experiences with the device.

  • SeaSpine Acquires Israeli Spine Technology For Estimated 52.5M
    SeaSpine Acquires Israeli Spine Technology For Estimated 52.5M

    SeaSpine has acquired Israeli medtech NLT and its platform of minimally invasive fusion technologies for degenerative spine disease. SeaSpine CEO Keith Valentine remarked that the deal, potentially worth $52.5 million in cash and stock, marks the newly spun-off company’s commitment to innovation through acquisition.

  • Regenerative Bandage For Diabetic Foot Ulcers Mimics Natural Healing Process
    Regenerative Bandage For Diabetic Foot Ulcers Mimics Natural Healing Process

    A novel wound dressing for diabetic foot ulcers uses biomaterials science to compensate for the healing limitations experienced by diabetic patients.  Researchers from Northwestern University claim the “regenerative bandage” promotes healing four times faster than a traditional bandage, and promotes a more natural healing process, without unnecessary and dangerous side effects.

  • Drug-Delivering Nanorobots Target Cancer Growth Hotspots
    Drug-Delivering Nanorobots Target Cancer Growth Hotspots

    By combining nanotechnology with bacteria, a team of Canadian scientists has developed a platform for cancer drug delivery it claims is highly precise in targeting cancerous cells. The team’s nanobots are equipped with oxygen sensors that can seek out areas of oxygen depletion in a tumor, which is indicative of active cancer growth.

  • Is Apple Pushing Further Into Healthcare With New Patent?
    Is Apple Pushing Further Into Healthcare With New Patent?

    Apple has filed a patent for a wearable device capable of collecting electrocardiographic (EKG) signals from various points on the body, technology that could be developed into wrist bands, pendants, brooches, or rings. The patent lends credibility to rumors surfacing last week that Apple was working on a stand-alone health-centric device separate from the Apple watch.

  • Brain Training, Robotics Restore Partial Mobility To Paraplegics
    Brain Training, Robotics Restore Partial Mobility To Paraplegics

    Next-generation prosthetics and exoskeletons are using brain-machine interfaces (BMIs) to restore mobility by connecting machines to the same neural circuitry that controlled the limbs of paraplegics prior to injury or stroke. Now, scientists at Duke University have demonstrated research that shows a similar brain-machine interface — a combination of “brain training,” virtual reality, and robotics—can restore partial sensation and movement to limbs paralyzed for years, even decades.

More Articles by Suzanne Hodsden

Suzanne Hodsden

Suzanne Hodsden is a contributor who writes regular life sciences news features for several publications. She holds degrees from Denison University and Bowling Green State University.